Corbus Pharmaceuticals CRBP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 12.65 | 104.61 | -1.90 | -24,417 | -23 | |
| 2025Q2 | 6.90 | 108.44 | -1.44 | -19,152 | -18 | |
| 2025Q1 | 5.31 | 116.47 | -1.39 | -19,775 | -17 | |
| 2024Q4 | 11.80 | 132.27 | -0.76 | -12,605 | -10 | |
| 2024Q3 | 20.63 | 115.69 | -1.17 | -15,505 | -14 | |
| 2024Q2 | 45.25 | 117.58 | -0.92 | -10,988 | -10 | |
| 2024Q1 | 39.24 | 143.16 | -0.83 | -9,623 | -7 | |
| 2023Q4 | 6.04 | 125.89 | -1.79 | -10,103 | -8 | |
| 2023Q3 | 6.74 | 96.97 | -2.25 | -9,488 | -10 | |
| 2023Q2 | 7.84 | 102.26 | -2.03 | -8,189 | -9 | |
| 2023Q1 | 7.27 | 101.35 | -4.24 | -17,297 | -18 | |
| 2022Q4 | 3.32 | 105.46 | -2.60 | -10,797 | -11 | |
| 2022Q3 | 4.95 | 99.30 | -2.11 | -8,181 | -9 | |
| 2022Q2 | 7.57 | 96.72 | -3.18 | -12,340 | -13 | |
| 2022Q1 | 15.95 | 94.87 | -2.26 | -8,517 | -9 | |
| 2021Q4 | 18.47 | 101.31 | -2.45 | -9,998 | -10 | |
| 2021Q3 | 30.60 | 777.75 | -0.30 | -13,875 | -2 | |
| 2021Q2 | 54.90 | 99.78 | -4.20 | -16,701 | -17 | |
| 2021Q1 | 59.10 | 99.97 | -4.20 | -15,414 | -16 | |
| 2020Q4 | 37.50 | 262.38 | -1.50 | -20,812 | -9 |